Increased respiratory morbidity in individuals with interstitial lung abnormalities
Open Access
- 19 March 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in BMC Pulmonary Medicine
- Vol. 20 (1), 1-10
- https://doi.org/10.1186/s12890-020-1107-0
Abstract
Interstitial lung abnormalities (ILA) are common in participants of lung cancer screening trials and broad population-based cohorts. They are associated with increased mortality, but less is known about disease specific morbidity and healthcare utilisation in individuals with ILA. We included all participants from the screening arm of the Danish Lung Cancer Screening Trial with available baseline CT scan data (n = 1990) in this cohort study. The baseline scan was scored for the presence of ILA and patients were followed for up to 12 years. Data about all hospital admissions, primary healthcare visits and medicine prescriptions were collected from the Danish National Health Registries and used to determine the participants’ disease specific morbidity and healthcare utilisation using Cox proportional hazards models. The 332 (16.7%) participants with ILA were more likely to be diagnosed with one of several respiratory diseases, including interstitial lung disease (HR: 4.9, 95% CI: 1.8–13.3, p = 0.008), COPD (HR: 1.7, 95% CI: 1.2–2.3, p = 0.01), pneumonia (HR: 2.0, 95% CI: 1.4–2.7, p < 0.001), lung cancer (HR: 2.7, 95% CI: 1.8–4.0, p < 0.001) and respiratory failure (HR: 1.8, 95% CI: 1.1–3.0, p = 0.03) compared with participants without ILA. These findings were confirmed by increased hospital admission rates with these diagnoses and more frequent prescriptions for inhalation medicine and antibiotics in participants with ILA. Individuals with ILA are more likely to receive a diagnosis and treatment for several respiratory diseases, including interstitial lung disease, COPD, pneumonia, lung cancer and respiratory failure during long-term follow-up.Keywords
Other Versions
Funding Information
- P. A. Messerschmidt og Hustrus Fond
- Skibsreder Per Henriksen, R og Hustrus Fond
- Roche a/s
This publication has 38 references indexed in Scilit:
- Epidemiology of idiopathic pulmonary fibrosisClinical Epidemiology, 2013
- Risk factors for community-acquired pneumonia in adults in Europe: a literature reviewThorax, 2013
- Subclinical Interstitial Lung DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2012
- Interstitial Lung Abnormalities and Reduced Exercise CapacityAmerican Journal of Respiratory and Critical Care Medicine, 2012
- An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and ManagementAmerican Journal of Respiratory and Critical Care Medicine, 2011
- Lung Volumes and Emphysema in Smokers with Interstitial Lung AbnormalitiesThe New England Journal of Medicine, 2011
- Interstitial lung diseases in a lung cancer screening trialEuropean Respiratory Journal, 2011
- Cigarette Smoking Is Associated with Subclinical Parenchymal Lung DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2009
- Early Interstitial Lung Disease in Familial Pulmonary FibrosisAmerican Journal of Respiratory and Critical Care Medicine, 2007
- High prevalence of abnormal acid gastro-oesophageal reflux in idiopathic pulmonary fibrosisEuropean Respiratory Journal, 2006